215 related articles for article (PubMed ID: 26854581)
1. The role of hyaluronic acid inclusion on the energetics of encapsulation and release of a protein molecule from chitosan-based nanoparticles.
Al-Qadi S; Alatorre-Meda M; Martin-Pastor M; Taboada P; Remuñán-López C
Colloids Surf B Biointerfaces; 2016 May; 141():223-232. PubMed ID: 26854581
[TBL] [Abstract][Full Text] [Related]
2. Preparation of N,O-carboxymethyl chitosan nanoparticles as an insulin carrier.
Lin CC; Lin CW
Drug Deliv; 2009 Nov; 16(8):458-64. PubMed ID: 19839790
[TBL] [Abstract][Full Text] [Related]
3. Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.
Kalam MA
Int J Biol Macromol; 2016 Aug; 89():127-36. PubMed ID: 27126165
[TBL] [Abstract][Full Text] [Related]
4. Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
Umerska A; Corrigan OI; Tajber L
Int J Pharm; 2014 Dec; 477(1-2):102-12. PubMed ID: 25447822
[TBL] [Abstract][Full Text] [Related]
5. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
Al-Qadi S; Grenha A; Carrión-Recio D; Seijo B; Remuñán-López C
J Control Release; 2012 Feb; 157(3):383-90. PubMed ID: 21864592
[TBL] [Abstract][Full Text] [Related]
6. Chitosan-hyaluronic acid nanoparticles for gene silencing: the role of hyaluronic acid on the nanoparticles' formation and activity.
Al-Qadi S; Alatorre-Meda M; Zaghloul EM; Taboada P; Remunán-López C
Colloids Surf B Biointerfaces; 2013 Mar; 103():615-23. PubMed ID: 23274155
[TBL] [Abstract][Full Text] [Related]
7. Chitosan-Coated Alginate Nanoparticles Enhanced Absorption Profile of Insulin Via Oral Administration.
Jaafar MHM; Hamid KA
Curr Drug Deliv; 2019; 16(7):672-686. PubMed ID: 31250754
[TBL] [Abstract][Full Text] [Related]
8. Novel hyaluronic acid coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of doxorubicin.
Chen L; Zheng Y; Feng L; Liu Z; Guo R; Zhang Y
Int J Biol Macromol; 2019 Apr; 126():254-261. PubMed ID: 30584933
[TBL] [Abstract][Full Text] [Related]
9. Layer-by-layer deposition of chitosan nanoparticles as drug-release coatings for PCL nanofibers.
Sydow S; de Cassan D; Hänsch R; Gengenbach TR; Easton CD; Thissen H; Menzel H
Biomater Sci; 2018 Dec; 7(1):233-246. PubMed ID: 30511062
[TBL] [Abstract][Full Text] [Related]
10. Preparation, characterization and antibacterial activities of chitosan, N-trimethyl chitosan (TMC) and N-diethylmethyl chitosan (DEMC) nanoparticles loaded with insulin using both the ionotropic gelation and polyelectrolyte complexation methods.
Sadeghi AM; Dorkoosh FA; Avadi MR; Saadat P; Rafiee-Tehrani M; Junginger HE
Int J Pharm; 2008 May; 355(1-2):299-306. PubMed ID: 18206322
[TBL] [Abstract][Full Text] [Related]
11. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.
Oyarzun-Ampuero FA; Brea J; Loza MI; Torres D; Alonso MJ
Int J Pharm; 2009 Nov; 381(2):122-9. PubMed ID: 19467809
[TBL] [Abstract][Full Text] [Related]
12. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
13. In vitro release and biological activities of Carum copticum essential oil (CEO) loaded chitosan nanoparticles.
Esmaeili A; Asgari A
Int J Biol Macromol; 2015 Nov; 81():283-90. PubMed ID: 26257380
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
[TBL] [Abstract][Full Text] [Related]
15. Formulation, characterization and in vitro release study of 5-fluorouracil loaded chitosan nanoparticles.
Samy M; Abd El-Alim SH; Rabia AEG; Amin A; Ayoub MMH
Int J Biol Macromol; 2020 Aug; 156():783-791. PubMed ID: 32320805
[TBL] [Abstract][Full Text] [Related]
16. Effect of preparation parameters on ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Nazeri N; Avadi MR; Faramarzi MA; Safarian S; Tavoosidana G; Khoshayand MR; Amani A
Int J Biol Macromol; 2013 Nov; 62():642-6. PubMed ID: 24099942
[TBL] [Abstract][Full Text] [Related]
17. Microcapsules of alginate/chitosan containing magnetic nanoparticles for controlled release of insulin.
Finotelli PV; Da Silva D; Sola-Penna M; Rossi AM; Farina M; Andrade LR; Takeuchi AY; Rocha-Leão MH
Colloids Surf B Biointerfaces; 2010 Nov; 81(1):206-11. PubMed ID: 20688491
[TBL] [Abstract][Full Text] [Related]
18. Protein corona hampers targeting potential of MUC1 aptamer functionalized SN-38 core-shell nanoparticles.
Varnamkhasti BS; Hosseinzadeh H; Azhdarzadeh M; Vafaei SY; Esfandyari-Manesh M; Mirzaie ZH; Amini M; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2015 Oct; 494(1):430-44. PubMed ID: 26315125
[TBL] [Abstract][Full Text] [Related]
19. Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery.
Reis CP; Ribeiro AJ; Veiga F; Neufeld RJ; Damgé C
Drug Deliv; 2008 Feb; 15(2):127-39. PubMed ID: 18293199
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-coated chitosan nanoparticles: molecular weight-dependent effects on morphology and hyaluronic acid presentation.
Almalik A; Donno R; Cadman CJ; Cellesi F; Day PJ; Tirelli N
J Control Release; 2013 Dec; 172(3):1142-50. PubMed ID: 24103813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
